N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists (Q44472688)

3 December 2017

title

N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists (English)

1 reference

3 December 2017

0 references

Amy Hauck Newman

1 reference

3 December 2017

Jianjing Cao

1 reference

3 December 2017

Christina J Bennett

1 reference

3 December 2017

Michael J Robarge

1 reference

3 December 2017

Rebekah A Freeman

1 reference

3 December 2017

Robert R Luedtke

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

3 December 2017

published in

1 reference

3 December 2017

1 reference

3 December 2017

1 reference

3 December 2017

page(s)

2179-2183

1 reference

Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

Dopamine D3 receptor agents as potential new medications for drug addiction.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

The D3 dopamine receptor and substance dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

1 reference

7 January 2021

Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

Interactive SAR studies: rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

Structure-affinity relationship study on N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamides as potent and selective dopamine D(3) receptor ligands.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

Dopamine D3 receptor ligands with antagonist properties

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

Characterization of (125)I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

NGB 2904 and NGB 2849: two highly selective dopamine D3 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900389-5

7 January 2021

10.1016/S0960-894X(03)00389-5

Identifiers

DOI

1 reference

3 December 2017

1 reference